UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended ~~October 31, 2022~~April 30, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number 1-14959

BRADY CORPORATION

(Exact name of registrant as specified in its charter)


Wisconsin						39-0178960
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

6555 West Good Hope Road

Milwaukee, Wisconsin ~~53233~~53223

(Address of principal executive offices and zip code)

(414) 358-6600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share	BRC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of ~~November 15, 2022,~~May 16, 2023, there were ~~46,200,742~~45,911,762 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

Table of Contents

FORM 10-Q

BRADY CORPORATION

INDEX

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

October 31, 2022 July 31, 2022
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 114,471 $ 114,069
Accounts receivable, net of allowance for credit losses of $6,938 and $7,355, respectively 180,183 183,233
Inventories 195,695 190,023
Prepaid expenses and other current assets 12,902 10,743
Total current assets 503,251 498,068
Property, plant and equipment—net 136,320 139,511
Goodwill 579,404 586,832
Other intangible assets 69,494 74,028
Deferred income taxes 15,061 15,881
Operating lease assets 27,244 31,293
Other assets 19,855 21,719
Total $ 1,350,629 $ 1,367,332
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 79,604 $ 81,116
Accrued compensation and benefits 57,095 76,764
Taxes, other than income taxes 13,495 12,539
Accrued income taxes 13,943 8,294
Current operating lease liabilities 14,126 15,003
Other current liabilities 65,350 61,458
Total current liabilities 243,613 255,174
Long-term debt 99,000 95,000
Long-term operating lease liabilities 15,558 19,143
Other liabilities 80,733 86,717
Total liabilities 438,904 456,034
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 46,176,267 and 46,370,708 shares, respectively 513 513
Class B voting common stock—Issued and outstanding, 3,538,628 shares 35 35
Additional paid-in capital 346,064 345,266
Retained earnings 920,482 892,417
Treasury stock—5,085,220 and 4,890,779 shares, respectively, of Class A nonvoting common stock, at cost (228,855) (217,856)
Accumulated other comprehensive loss (126,514) (109,077)
Total stockholders’ equity 911,725 911,298
Total $ 1,350,629 $ 1,367,332


	April 30, 2023		July 31, 2022
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	135,047	$	114,069
Accounts receivable, net of allowance for credit losses of $8,417 and $7,355, respectively	184,907		183,233
Inventories	182,809		190,023
Prepaid expenses and other current assets	14,020		10,743
Total current assets	516,783		498,068
Property, plant and equipment—net	139,747		139,511
Goodwill	590,684		586,832
Other intangible assets	65,210		74,028
Deferred income taxes	15,124		15,881
Operating lease assets	27,378		31,293
Other assets	21,840		21,719
Total	$	1,376,766	$	1,367,332
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	74,745	$	81,116
Accrued compensation and benefits	65,789		76,764
Taxes, other than income taxes	13,246		12,539
Accrued income taxes	5,103		8,294
Current operating lease liabilities	14,196		15,003
Other current liabilities	63,357		61,458
Total current liabilities	236,436		255,174
Long-term debt	50,849		95,000
Long-term operating lease liabilities	14,573		19,143
Other liabilities	79,812		86,717
Total liabilities	381,670		456,034
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 45,935,672 and 46,370,708 shares, respectively	513		513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35		35
Additional paid-in capital	350,758		345,266
Retained earnings	983,694		892,417
Treasury stock—5,325,815 and 4,890,779 shares, respectively, of Class A nonvoting common stock, at cost	(244,503)		(217,856)
Accumulated other comprehensive loss	(95,401)		(109,077)
Total stockholders’ equity	995,096		911,298
Total	$	1,376,766	$	1,367,332

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Thousands, Except Per Share Amounts, Unaudited)

Three months ended October 31,
2022 2021
Net sales $ 322,569 $ 321,475
Cost of goods sold 167,305 166,487
    Gross margin 155,264 154,988
Operating expenses:
    Research and development 13,933 13,907
    Selling, general and administrative 89,945 96,746
Total operating expenses 103,878 110,653
Operating income 51,386 44,335
Other (expense) income:
    Investment and other (expense) income (157) 543
    Interest expense (894) (182)
Income before income taxes 50,335 44,696
Income tax expense 10,894 9,650
Net income $ 39,441 $ 35,046
Net income per Class A Nonvoting Common Share:
    Basic $ 0.79 $ 0.67
    Diluted $ 0.79 $ 0.67
Net income per Class B Voting Common Share:
    Basic $ 0.78 $ 0.66
    Diluted $ 0.77 $ 0.65
Weighted average common shares outstanding:
Basic 49,868 51,973
Diluted 50,090 52,436


	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
Net sales	$	337,116	$	338,551	$	985,934	$	978,081
Cost of goods sold	167,425		174,525		504,539		509,705
Gross margin	169,691		164,026		481,395		468,376
Operating expenses:
Research and development	15,715		14,923		45,025		42,795
Selling, general and administrative	90,975		96,214		273,202		285,485
Total operating expenses	106,690		111,137		318,227		328,280
Operating income	63,001		52,889		163,168		140,096
Other income (expense):
Investment and other income (expense)	785		(1,308)		1,596		(1,343)
Interest expense	(753)		(329)		(2,886)		(763)
Income before income taxes	63,033		51,252		161,878		137,990
Income tax expense	14,981		11,198		36,399		29,075
Net income	$	48,052	$	40,054	$	125,479	$	108,915
Net income per Class A Nonvoting Common Share:
Basic	$	0.97	$	0.78	$	2.52	$	2.11
Diluted	$	0.96	$	0.78	$	2.51	$	2.09
Net income per Class B Voting Common Share:
Basic	$	0.97	$	0.78	$	2.51��	$	2.09
Diluted	$	0.96	$	0.78	$	2.49	$	2.08
Weighted average common shares outstanding:
Basic	49,653		51,326		49,755		51,700
Diluted	50,001		51,568		50,033		52,055

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Thousands, Unaudited)

Three months ended October 31,
2022 2021
Net income $ 39,441 $ 35,046
Other comprehensive loss:
Foreign currency translation adjustments (17,672) (3,918)
Cash flow hedges:
Net gain (loss) recognized in other comprehensive loss 893 (26)
Reclassification adjustment for gains included in net income (581) (568)
312 (594)
Pension and other post-retirement benefits actuarial gain amortization (143) (107)
Other comprehensive loss, before tax (17,503) (4,619)
Income tax benefit (expense) related to items of other comprehensive loss 66 (99)
Other comprehensive loss, net of tax (17,437) (4,718)
Comprehensive income $ 22,004 $ 30,328


	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
Net income	$	48,052	$	40,054	$	125,479	$	108,915
Other comprehensive (loss) income:
Foreign currency translation adjustments	95		(20,180)		12,985		(42,754)

Cash flow hedges:
Net gain recognized in other comprehensive (loss) income	496		475		2,165		674
Reclassification adjustment for gains included in net income	(463)		(44)		(1,261)		(647)
	33		431		904		27
Pension and other post-retirement benefits:
Net loss recognized in other comprehensive (loss) income	—		—		—		(85)
Net actuarial gain amortization	(151)		(95)		(267)		(275)
	(151)		(95)		(267)		(360)

Other comprehensive (loss) income, before tax	(23)		(19,844)		13,622		(43,087)
Income tax (expense) benefit related to items of other comprehensive (loss) income	(8)		(105)		54		152
Other comprehensive (loss) income, net of tax	(31)		(19,949)		13,676		(42,935)
Comprehensive income	$	48,021	$	20,105	$	139,155	$	65,980

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Dollars in Thousands, Unaudited)


		Three months ended October 31, 2022													Three months ended April 30, 2023
		Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity			Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2022		$	548	$	345,266	$	892,417	$	(217,856)	$	(109,077)	$	911,298
Balances at January 31, 2023														Balances at January 31, 2023	$	548	$	348,513	$	947,051	$	(233,338)	$	(95,370)	$	967,404
Net income	Net income	—		—		39,441		—		—		39,441		Net income	—		—		48,052		—		—		48,052
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	—		—		—		—		(17,437)		(17,437)		Other comprehensive loss, net of tax	—		—		—		—		(31)		(31)
Issuance of shares of Class A Common Stock under stock plan	Issuance of shares of Class A Common Stock under stock plan	—		(2,226)		—		1,071		—		(1,155)		Issuance of shares of Class A Common Stock under stock plan	—		199		—		748		—		947
Tax benefit and withholdings from deferred compensation distributions		—		66		—		—		—		66
Stock-based compensation expense	Stock-based compensation expense	—		2,958		—		—		—		2,958		Stock-based compensation expense	—		2,046		—		—		—		2,046
Repurchase of shares of Class A Common Stock	Repurchase of shares of Class A Common Stock	—		—		—		(12,070)		—		(12,070)		Repurchase of shares of Class A Common Stock	—		—		—		(11,913)		—		(11,913)
Cash dividends on Common Stock:	Cash dividends on Common Stock:													Cash dividends on Common Stock:
Class A — $0.2300 per share	Class A — $0.2300 per share	—		—		(10,621)		—		—		(10,621)		Class A — $0.2300 per share	—		—		(10,595)		—		—		(10,595)
Class B — $0.2134 per share		—		—		(755)		—		—		(755)
Balances at October 31, 2022		$	548	$	346,064	$	920,482	$	(228,855)	$	(126,514)	$	911,725
Class B — $0.2300 per share														Class B — $0.2300 per share	—		—		(814)		—		—		(814)
Balances at April 30, 2023														Balances at April 30, 2023	$	548	$	350,758	$	983,694	$	(244,503)	$	(95,401)	$	995,096


		Three months ended October 31, 2021													Nine months ended April 30, 2023
		Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity			Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2021		$	548	$	339,125	$	788,369	$	(109,061)	$	(55,953)	$	963,028
Balances at July 31, 2022														Balances at July 31, 2022	$	548	$	345,266	$	892,417	$	(217,856)	$	(109,077)	$	911,298
Net income	Net income	—		—		35,046		—		—		35,046		Net income	—		—		125,479		—		—		125,479
Other comprehensive loss, net of tax		—		—		—		—		(4,718)		(4,718)
Other comprehensive income, net of tax														Other comprehensive income, net of tax	—		—		—		—		13,676		13,676
Issuance of shares of Class A Common Stock under stock plan	Issuance of shares of Class A Common Stock under stock plan	—		(3,187)		—		(1)		—		(3,188)		Issuance of shares of Class A Common Stock under stock plan	—		(1,001)		—		3,127		—		2,126
Tax benefit and withholdings from deferred compensation distributions	Tax benefit and withholdings from deferred compensation distributions	—		115		—		—		—		115		Tax benefit and withholdings from deferred compensation distributions	—		66		—		—		—		66
Stock-based compensation expense	Stock-based compensation expense	—		4,129		—		—		—		4,129		Stock-based compensation expense	—		6,427		—		—		—		6,427
Repurchase of shares of Class A Common Stock	Repurchase of shares of Class A Common Stock	—		—		—		(18,924)		—		(18,924)		Repurchase of shares of Class A Common Stock	—		—		—		(29,774)		—		(29,774)
Cash dividends on Common Stock:	Cash dividends on Common Stock:													Cash dividends on Common Stock:
Class A — $0.2250 per share		—		—		(10,858)		—		—		(10,858)
Class B — $0.2084 per share		—		—		(737)		—		—		(737)
Balances at October 31, 2021		$	548	$	340,182	$	811,820	$	(127,986)	$	(60,671)	$	963,893
Class A — $0.6900 per share														Class A — $0.6900 per share	—		—		(31,819)		—		—		(31,819)
Class B — $0.6734 per share														Class B — $0.6734 per share	—		—		(2,383)		—		—		(2,383)
Balances at April 30, 2023														Balances at April 30, 2023	$	548	$	350,758	$	983,694	$	(244,503)	$	(95,401)	$	995,096

Table of Contents


	Three months ended April 30, 2022
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at January 31, 2022	$	548	$	341,889	$	833,981	$	(130,911)	$	(78,939)	$	966,568
Net income	—		—		40,054		—		—		40,054
Other comprehensive loss, net of tax	—		—		—		—		(19,949)		(19,949)
Issuance of shares of Class A Common Stock under stock plan	—		(18)		—		262		—		244
Stock-based compensation expense	—		1,983		—		—		—		1,983
Repurchase of shares of Class A Common Stock	—		—		—		(63,210)		—		(63,210)
Cash dividends on Common Stock:
Class A — $0.2250 per share	—		—		(10,655)		—		—		(10,655)
Class B — $0.2250 per share	—		—		(797)		—		—		(797)
Balances at April 30, 2022	$	548	$	343,854	$	862,583	$	(193,859)	$	(98,888)	$	914,238


	Nine months ended April 30, 2022
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2021	$	548	$	339,125	$	788,369	$	(109,061)	$	(55,953)	$	963,028
Net income	—		—		108,915		—		—		108,915
Other comprehensive loss, net of tax	—		—		—		—		(42,935)		(42,935)
Issuance of shares of Class A Common Stock under stock plan	—		(4,539)		—		132		—		(4,407)
Tax benefit and withholdings from deferred compensation distributions	—		115		—		—		—		115
Stock-based compensation expense	—		9,153		—		—		—		9,153
Repurchase of shares of Class A Common Stock	—		—		—		(84,930)		—		(84,930)
Cash dividends on Common Stock:
Class A — $0.6750 per share	—		—		(32,370)		—		—		(32,370)
Class B — $0.6584 per share	—		—		(2,331)		—		—		(2,331)
Balances at April 30, 2022	$	548	$	343,854	$	862,583	$	(193,859)	$	(98,888)	$	914,238

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands, Unaudited)

Three months ended October 31,
2022 2021
Operating activities:
Net income $ 39,441 $ 35,046
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 8,665 8,509
Stock-based compensation expense 2,958 4,129
Deferred income taxes (1,705) (625)
Other (383) (187)
Changes in operating assets and liabilities:
Accounts receivable (627) (13,302)
Inventories (9,582) (16,579)
Prepaid expenses and other assets (2,563) (655)
Accounts payable and accrued liabilities (14,150) 9,499
Income taxes 5,945 1,656
Net cash provided by operating activities 27,999 27,491
Investing activities:
Purchases of property, plant and equipment (3,861) (11,328)
Other — 2
Net cash used in investing activities (3,861) (11,326)
Financing activities:
Payment of dividends (11,376) (11,595)
Proceeds from exercise of stock options 349 151
Payments for employee taxes withheld from stock-based awards (1,504) (3,339)
Purchase of treasury stock (12,070) (18,924)
Proceeds from borrowing on credit facilities 36,000 56,200
Repayment of borrowing on credit facilities (32,000) (27,200)
Other 66 115
Net cash used in financing activities (20,535) (4,592)
Effect of exchange rate changes on cash and cash equivalents (3,201) (1,355)
Net increase in cash and cash equivalents 402 10,218
Cash and cash equivalents, beginning of period 114,069 147,335
Cash and cash equivalents, end of period $ 114,471 $ 157,553


	Nine months ended April 30,
	2023		2022
Operating activities:
Net income	$	125,479	$	108,915
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	24,522		25,448
Stock-based compensation expense	6,427		9,153
Gain on sale of business	(3,770)		—
Deferred income taxes	(5,947)		2,858
Other	(1,336)		(1,080)
Changes in operating assets and liabilities:
Accounts receivable	1,744		(26,438)
Inventories	9,279		(47,784)
Prepaid expenses and other assets	(3,429)		(932)
Accounts payable and accrued liabilities	(19,704)		(5,584)
Income taxes	(3,404)		680
Net cash provided by operating activities	129,861		65,236

Investing activities:
Purchases of property, plant and equipment	(12,912)		(22,130)
Sale of business	8,000		—
Other	11		59
Net cash used in investing activities	(4,901)		(22,071)

Financing activities:
Payment of dividends	(34,202)		(34,701)
Proceeds from exercise of stock options	4,091		663
Payments for employee taxes withheld from stock-based awards	(1,965)		(5,070)
Purchase of treasury stock	(29,774)		(84,930)
Proceeds from borrowing on credit agreement	102,916		155,216
Repayment of borrowing on credit agreement	(147,067)		(116,216)
Other	66		3,276
Net cash used in financing activities	(105,935)		(81,762)

Effect of exchange rate changes on cash and cash equivalents	1,953		(5,670)

Net increase (decrease) in cash and cash equivalents	20,978		(44,267)
Cash and cash equivalents, beginning of period	114,069		147,335

Cash and cash equivalents, end of period	$	135,047	$	103,068

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~Three~~Nine Months Ended ~~October 31, 2022~~April 30, 2023

(Unaudited)

(In thousands, except share and per share amounts)

NOTE A — Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the "Company," "Brady," "we," or "our") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of ~~October 31, 2022~~April 30, 2023 and July 31, 2022, its results of operations ~~cash flows~~ and comprehensive income for the three and nine months ended ~~October 31,~~April 30, 2023 and 2022, and ~~2021.~~cash flows for the nine months ended April 30, 2023 and 2022. The condensed consolidated balance sheet as of July 31, 2022 has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2022.

NOTE B — New Accounting Pronouncements

Adopted Standards

In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities (e.g. deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers” as if the acquirer had originated the contracts. The guidance is applied prospectively to acquisitions occurring on or after the effective date. The Company early adopted ASU No. 2021-08 during the quarter ended October 31, 2022. The adoption of the new standard will only have an impact on the Company's condensed consolidated financial statements in the event of future acquisitions.

NOTE C — Additional Balance Sheet Information

Inventories

Inventories as of ~~October 31, 2022~~April 30, 2023 and July 31, 2022, consisted of the following:


		October 31, 2022		July 31, 2022			April 30, 2023		July 31, 2022
Finished products	Finished products	$	111,897	$	112,323	Finished products	$	103,623	$	112,323
Work-in-process	Work-in-process	30,359		29,272		Work-in-process	28,802		29,272
Raw materials and supplies	Raw materials and supplies	53,439		48,428		Raw materials and supplies	50,384		48,428
Total inventories	Total inventories	$	195,695	$	190,023	Total inventories	$	182,809	$	190,023

Property, plant and equipment

Property, plant and equipment is presented net of accumulated depreciation in the amount of ~~$273,922~~$287,368 and $272,376 as of ~~October 31, 2022~~April 30, 2023 and July 31, 2022, respectively.

Table of Contents

NOTE D — Goodwill and Other Intangible Assets

Changes in the carrying amount of goodwill for the nine months ended April 30, 2023 were as follows:


	IDS		WPS		Americas & Asia		Europe & Australia		Total
Balance as of July 31, 2022	$	556,151	$	30,681	$	—	$	—	$	586,832
Translation adjustments	3,319		625		—		—		3,944
Balance as of January 31, 2023	559,470		31,306		—		—		590,776
Reallocation due to change in segments	(559,470)		(31,306)		442,290		148,486		—
Divestiture of business	—		—		(1,954)		—		(1,954)
Translation adjustments	—		—		382		1,480		1,862
Balance as of April 30, 2023	$	—	$	—	$	440,718	$	149,966	$	590,684

Effective February 1, 2023, the Company is organized and managed within two regions: Americas & Asia and Europe & Australia, which are the reportable segments. Prior to February 1, 2023, the Company was organized and managed on a global basis within two business platforms: Identification Solutions ("IDS") and Workplace Safety ("WPS"). As a result, goodwill was allocated to the new reportable segments in accordance with ASC 350, "Intangibles - Goodwill and Other." Refer to Note H, "Segment Information," and Management's Discussion and Analysis for additional information regarding the Company's segment change.

During the nine-month period ended April 30, 2023, goodwill increased $3,852 primarily due to the positive effects of foreign currency translation, which was partially offset by a reduction due to the sale of our PremiSys business within the Americas & Asia segment during the three months ended April 30, 2023.

Other intangible assets as of ~~October 31, 2022~~April 30, 2023 and July 31, 2022, consisted of the following:


		October 31, 2022							July 31, 2022								April 30, 2023							July 31, 2022
		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value			Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Amortized other intangible assets:	Amortized other intangible assets:															Amortized other intangible assets:
Tradenames	Tradenames	3	$	1,728	$	(1,165)	$	563	3	$	1,749	$	(1,014)	$	735	Tradenames	3	$	1,762	$	(1,525)	$	237	3	$	1,749	$	(1,014)	$	735
Customer relationships	Customer relationships	9	104,610		(51,312)		53,298		9	105,404		(48,428)		56,976		Customer relationships	9	64,049		(13,996)		50,053		9	105,404		(48,428)		56,976
Technology	Technology	5	9,013		(2,686)		6,327		5	9,136		(2,241)		6,895		Technology	5	9,241		(3,718)		5,523		5	9,136		(2,241)		6,895
Unamortized other intangible assets:	Unamortized other intangible assets:															Unamortized other intangible assets:
Tradenames	Tradenames	N/A	9,306		—		9,306		N/A	9,422		—		9,422		Tradenames	N/A	9,397		—		9,397		N/A	9,422		—		9,422
Total	Total		$	124,657	$	(55,163)	$	69,494		$	125,711	$	(51,683)	$	74,028	Total		$	84,449	$	(19,239)	$	65,210		$	125,711	$	(51,683)	$	74,028

The ~~change~~decrease in the gross carrying amount and accumulated amortization of other intangible assets as of ~~October 31, 2022~~April 30, 2023 compared to July 31, 2022 was primarily due to the ~~effect~~removal of ~~currency fluctuations during~~a fully amortized customer relationship intangible asset as the ~~three-month period.~~ period of economic benefit related to this asset has lapsed.

Amortization expense onof intangible assets was ~~$3,631~~$2,461 and ~~$3,807~~$3,735 for the three months ended ~~October 31,~~April 30, 2023 and 2022, respectively, and ~~2021,~~$9,350 and $11,291 for the nine months ended April 30, 2023 and 2022, respectively.

NOTE E — Leases

The Company leases certain manufacturing facilities, warehouse and office spaces, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of ~~October 31, 2022,~~April 30, 2023, the Company did not have any finance leases.

Operating lease expense was ~~$3,780~~$3,997 and ~~$4,765~~$4,346 for the three months ended ~~October 31,~~April 30, 2023 and 2022, respectively, and ~~2021,~~$11,645 and $13,198 for the nine months ended April 30, 2023 and 2022, respectively, which was recognized in either "Cost of goods sold" or "Selling, general and administrative" expenses in the condensed consolidated statements of income, based on the

Table of Contents

nature of the lease. Short-term lease expense, variable lease expenses, and sublease income was immaterial to the condensed consolidated statements of income for the three and nine months ended ~~October 31, 2022~~April 30, 2023 and ~~2021.~~2022.

Supplemental cash flow information related to the Company's operating leases for the ~~three~~nine months ended ~~October 31,~~April 30, 2023 and 2022, ~~and 2021~~was~~, was~~ as follows:

Three months ended October 31,
2022 2021
Operating cash flows from operating leases $ 4,202 $ 4,999
Operating lease assets obtained in exchange for new operating lease liabilities (1) (2)
102 (868)


	Nine months ended April 30,
	2023		2022
Operating cash outflows from operating leases	$	13,196	$	14,582
Operating lease assets obtained in exchange for new operating lease liabilities (1)	6,545		2,553

(1) Includes new leases and remeasurements or modifications of existing ~~leases.~~

~~(2)~~ leasesDuring the three months ended October 31, 2021, the Company purchased two buildings which were previously leased. This resulted in a decrease in operating lease assets obtained in exchange for lease liabilities for the period as the remaining lease assets and liabilities were removed from the condensed consolidated balance sheets..

~~Table of Contents~~

NOTE F — Accumulated Other Comprehensive Loss

Other comprehensive loss consists of foreign currency translation adjustments, ~~the~~ unrealized ~~gain~~gains and losses from cash flow hedges, and the unamortized gain on post-retirement plans, net of their related tax effects.

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the ~~three~~nine months ended ~~October 31, 2022:~~April 30, 2023:


		Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss			Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2022	Beginning balance, July 31, 2022	$	954	$	1,436	$	(111,467)	$	(109,077)	Beginning balance, July 31, 2022	$	954	$	1,436	$	(111,467)	$	(109,077)
Other comprehensive income (loss) before reclassification		813		—		(17,672)		(16,859)
Other comprehensive income before reclassification										Other comprehensive income before reclassification	1,966		—		12,985		14,951
Amounts reclassified from accumulated other comprehensive loss	Amounts reclassified from accumulated other comprehensive loss	(435)		(143)		—		(578)		Amounts reclassified from accumulated other comprehensive loss	(946)		(329)		—		(1,275)
Ending balance, October 31, 2022		$	1,332	$	1,293	$	(129,139)	$	(126,514)
Ending balance, April 30, 2023										Ending balance, April 30, 2023	$	1,974	$	1,107	$	(98,482)	$	(95,401)

The ~~increase~~decrease in accumulated other comprehensive loss as of ~~October 31, 2022,~~April 30, 2023 compared to July 31, 2022 was primarily due to the ~~appreciation~~depreciation of the U.S. dollar against certain other currencies during the ~~three-month~~nine-month period. The foreign currency translation adjustments column in the table above includes the impact of foreign currency translation, foreign currency translation on intercompany notes, and the settlements of net investment hedges, net of tax.

The changes in accumulated other comprehensive loss by component, net of tax, for the ~~three~~nine months ended ~~October 31, 2021,~~April 30, 2022 were as follows:


		Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss			Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2021	Beginning balance, July 31, 2021	$	729	$	1,888	$	(58,570)	$	(55,953)	Beginning balance, July 31, 2021	$	729	$	1,888	$	(58,570)	$	(55,953)
Other comprehensive loss before reclassification		(273)		—		(3,913)		(4,186)
Other comprehensive income (loss) before reclassification										Other comprehensive income (loss) before reclassification	307		(59)		(42,408)		(42,160)
Amounts reclassified from accumulated other comprehensive loss	Amounts reclassified from accumulated other comprehensive loss	(425)		(107)		—		(532)		Amounts reclassified from accumulated other comprehensive loss	(486)		(289)		—		(775)
Ending balance, October 31, 2021		$	31	$	1,781	$	(62,483)	$	(60,671)
Ending balance, April 30, 2022										Ending balance, April 30, 2022	$	550	$	1,540	$	(100,978)	$	(98,888)

The increase in ~~the~~ accumulated other comprehensive loss as of ~~October 31, 2021,~~April 30, 2022 compared to July 31, 2021, was primarily due to the appreciation of the U.S. dollar against certain other currencies during the ~~three-month~~nine-month period.

Of the amounts reclassified from accumulated other comprehensive loss during the ~~three~~nine months ended ~~October 31,~~April 30, 2023 and 2022, ~~and 2021,~~ unrealized gains on cash flow hedges were reclassified to "Cost of goods sold" and unamortized gains on post-retirement plans ~~was~~were reclassified into "Investment and other ~~(expense)~~ income" on the condensed consolidated statements of income.

Table of Contents

The following table illustrates the income tax (expense) benefit ~~(expense)~~ on the components of other comprehensive ~~loss~~(loss) income for the three and nine months ended ~~October 31, 2022~~April 30, 2023 and ~~2021:~~2022:


		Three months ended October 31,					Three months ended April 30,				Nine months ended April 30,
		2022		2021			2023		2022		2023		2022
Income tax benefit (expense) related to items of other comprehensive loss:
Income tax (expense) benefit related to items of other comprehensive (loss) income:						Income tax (expense) benefit related to items of other comprehensive (loss) income:
Cash flow hedges	Cash flow hedges	$	66	$	(104)	Cash flow hedges	$	(8)	$	(15)	$	116	$	(206)
Pension and other post-retirement benefits						Pension and other post-retirement benefits	—		(3)		(62)		12
Other income tax adjustments and currency translation	Other income tax adjustments and currency translation	—		5		Other income tax adjustments and currency translation	—		(87)		—		346
Income tax benefit (expense) related to items of other comprehensive loss		$	66	$	(99)
Income tax (expense) benefit related to items of other comprehensive (loss) income						Income tax (expense) benefit related to items of other comprehensive (loss) income	$	(8)	$	(105)	$	54	$	152

NOTE G — Revenue Recognition

The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note H, “Segment Information,” for the Company’s disaggregated revenue disclosure.

The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a

~~Table of Contents~~

contract liability. The balance of contract liabilities associated with service warranty performance obligations was ~~$2,727~~$2,737 and $2,675 as of ~~October 31, 2022~~April 30, 2023 and July 31, 2022, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities," respectively, on the condensed consolidated balance sheets. The Company recognized revenue of ~~$306~~$311 and ~~$289~~$297 during the three months ended ~~October 31,~~April 30, 2023 and 2022, respectively, and ~~2021,~~$928 and $882 during the nine months ended April 30, 2023 and 2022, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at ~~October 31, 2022,~~April 30, 2023, the Company expects to recognize ~~32%~~12% by the end of fiscal 2023, an additional ~~31%~~37% by the end of fiscal 2024, and the remaining balance thereafter.

NOTE H — Segment Information

~~The~~Effective February 1, 2023, the Company is organized and managed within two regions: Americas & Asia and Europe & Australia, which are the reportable segments. Prior to February 1, 2023, the Company was organized and managed on a global basis within three operating ~~segments,~~segments: Identification Solutions ~~("IDS"), Workplace Safety ("WPS"),~~ and People Identification ("PDC"), which ~~aggregate into two reportable segments that are organized around businesses with consistent products and services: IDS and WPS. The IDS and PDC operating segments aggregate~~aggregated into the IDS ~~reporting~~reportable segment, ~~while~~and Workplace Safety ("WPS"), which was the WPS ~~reporting segment is comprised solely~~reportable segment. As such, all segment-related data has been recast to the new reportable segments.

Table of ~~the Workplace Safety operating segment.~~Contents

The following is a summary of net sales by segment and geographic region for the three and nine months ended ~~October 31, 2022~~April 30, 2023 and ~~2021:~~2022:


		Three months ended October 31,					Three months ended April 30,				Nine months ended April 30,
		2022		2021			2023		2022		2023		2022
Net sales:	Net sales:					Net sales:
IDS
Americas & Asia						Americas & Asia
Americas	Americas	$	173,349	$	164,910	Americas	$	198,074	$	196,266	$	584,505	$	560,184
Europe		56,643		56,889
Asia	Asia	26,364		26,818		Asia	24,739		26,313		76,870		83,108
Total	Total	$	256,356	$	248,617	Total	$	222,813	$	222,579	$	661,375	$	643,292
WPS
Americas		$	18,782	$	21,142
Europe & Australia						Europe & Australia
Europe	Europe	33,549		38,022		Europe	$	100,480	$	102,809	$	284,432	$	296,426
Australia	Australia	13,882		13,694		Australia	13,823		13,163		40,127		38,363
Total	Total	$	66,213	$	72,858	Total	$	114,303	$	115,972	$	324,559	$	334,789

Total Company	Total Company					Total Company	$	337,116	$	338,551	$	985,934	$	978,081
Americas		$	192,131	$	186,052
Europe		90,192		94,911
Asia-Pacific		40,246		40,512
Total		$	322,569	$	321,475

The following is a summary of segment profit for the three and nine months ended ~~October 31, 2022~~April 30, 2023 and ~~2021:~~2022:

Three months ended October 31,
2022 2021
Segment profit:
IDS $ 51,525 $ 48,816
WPS 6,378 2,293
Total Company $ 57,903 $ 51,109

~~Table of Contents~~


	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
Segment profit:
Americas & Asia	$	49,192	$	45,021	$	130,511	$	114,659
Europe & Australia	17,099		16,050		47,316		46,165
Total Company	$	66,291	$	61,071	$	177,827	$	160,824

The following is a reconciliation of segment profit to income before income taxes for the three and nine months ended ~~October 31, 2022~~April 30, 2023 and ~~2021:~~2022:

Three months ended October 31,
2022 2021
Total profit from reportable segments $ 57,903 $ 51,109
Unallocated amounts:
Administrative costs (6,517) (6,774)
Investment and other (expense) income (157) 543
Interest expense (894) (182)
Income before income taxes $ 50,335 $ 44,696

~~NOTE I – Stock-Based Compensation~~

~~Incentive Stock Plans~~

The Company has an incentive stock plan under which the Board of Directors may grant nonqualified stock options to purchase shares of Class A Nonvoting Common Stock, restricted stock units ("RSUs"), performance-based restricted stock units ("PRSUs"), or restricted and unrestricted shares of Class A Nonvoting Common Stock to employees and non-employee directors. Certain awards may be subject to pre-established performance goals. The majority of the Company’s annual share-based awards are granted in the first quarter of the fiscal year.

Total stock-based compensation expense recognized during the three months ended October 31, 2022 and 2021 was $2,958 and $4,129, respectively. The total income tax benefit recognized in the condensed consolidated statements of income was $192 and $199 during the three months ended October 31, 2022 and 2021, respectively.

~~Stock Options~~

The stock options issued under the plan have an exercise price equal to the market price of the Company's stock at the date of the grant and generally vest ratably over three years, with one-third becoming exercisable one year after the grant date and one-third additional in each of the succeeding two years. Options issued under the plan, referred to herein as “time-based” options, generally expire ten years from the date of grant.

The Company has estimated the fair value of its time-based option awards granted during the three months ended October 31, 2022 and 2021, using the Black-Scholes option valuation model. The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:

Three months ended October 31,
Black-Scholes Option Valuation Assumptions 2022 2021
Expected term (in years) 5.7 6.1
Expected volatility 29.6 % 30.0 %
Expected dividend yield 2.0 % 2.3 %
Risk-free interest rate 3.7 % 1.0 %


	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
Total profit from reportable segments	$	66,291	$	61,071	$	177,827	$	160,824
Unallocated amounts:
Administrative costs	(7,060)		(8,182)		(18,429)		(20,728)
Gain on sale of business	3,770		—		3,770		—
Investment and other income (expense)	785		(1,308)		1,596		(1,343)
Interest expense	(753)		(329)		(2,886)		(763)
Income before income taxes	$	63,033	$	51,252	$	161,878	$	137,990

The following is a summary of ~~stock option activity~~sales by business platform for the three and nine months ended ~~October 31,~~April 30, 2023 and 2022:

Time-Based Options Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
Outstanding at July 31, 2022 1,591,525 $ 41.57
Granted 147,629 43.50
Exercised (22,494) 30.48
Forfeited (10,247) 45.41
Outstanding at October 31, 2022 1,706,413 $ 41.86 6.4 $ 9,729
Exercisable at October 31, 2022 1,270,763 $ 40.67 5.4 $ 8,851


	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
IDS	$	262,984	$	264,124	$	775,023	$	757,727
WPS	74,132		74,427		210,911		220,354
Total Company	$	337,116	$	338,551	$	985,934	$	978,081

1213

Table of Contents

The weighted-average grant date fair value of options granted during the three months ended October 31, 2022 and 2021 was $12.06 and $11.29, respectively. The total intrinsic value of stock options exercised during the three months ended October 31, 2022 and 2021 was $364 and $319, respectively. The total fair value of stock options vested during the three months ended October 31, 2022 and 2021 was $2,458 and $2,446, respectively.

The cash received from the exercise of stock options during the three months ended October 31, 2022 and 2021 was $349 and $151, respectively. The tax benefit from the exercise of stock options during the three months ended October 31, 2022 and 2021 was $91 and $80, respectively.

As of October 31, 2022, total unrecognized compensation cost related to stock options was $2,898 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.1 years.

~~RSUs~~

RSUs issued under the plan have a grant date fair value equal to the market price of the Company's stock at the date of grant and generally vest ratably over three years, with one-third vesting one year after the grant date and one-third additional in each of the succeeding two years.

~~The following is a summary of RSU activity for the three months ended October 31, 2022:~~

Number of Shares Weighted Average Grant Date Fair Value
Non-vested RSUs as of July 31, 2022 173,230 $ 47.45
Granted 62,197 44.70
Vested (61,316) 47.50
Forfeited (2,585) 45.03
Non-vested RSUs as of October 31, 2022 171,526 $ 46.47

The RSUs granted during the three months ended October 31, 2021 had a weighted-average grant date fair value of $49.85. The total fair value of RSUs vested during three months ended October 31, 2022 and 2021 was $2,608 and $3,380, respectively.

As of October 31, 2022, total unrecognized compensation cost related to RSUs was $5,029 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.2 years.

~~PRSUs~~

~~PRSUs are contingent on the achievement of predetermined market and performance targets. The PRSUs granted under the plan vest at the end of a~~ ~~three~~-year performance period provided the specified market and performance targets are met. For the PRSUs granted during the three months ended October 31, 2022 and 2021, the vesting criteria for 50% of the grant is based upon the Company's total shareholder return ("TSR") relative to the S&P 600 SmallCap Industrials Index over a three-year performance period, and the vesting criteria for the other 50% of the grant is based upon Company revenue targets. All other previously granted non-vested PRSUs vest based upon the Company's TSR relative to the S&P 600 SmallCap Industrials Index.

The Company calculates the fair value of each component of the applicable PRSUs individually. The fair value of the revenue target metric, which is a performance condition, is equal to the average of the high and low stock price on the grant date. The fair value of the TSR metric, which is a market condition, is determined using a Monte Carlo valuation model. The assumptions used in the Monte Carlo valuation model are reflected in the following table:

Three months ended October 31,
Monte Carlo Valuation Assumptions 2022 2021
Expected volatility 34.8 % 34.7 %
Risk-free interest rate 2.8 % 0.3 %

~~Table of Contents~~

~~The following is a summary of PRSU activity for the three months ended October 31, 2022:~~

Number of Shares Weighted Average Grant Date Fair Value
Non-vested PRSUs as of July 31, 2022 79,134 $ 66.79
Granted 44,110 55.77
Vested (18,959) 75.00
Forfeited (16,332) 71.99
Non-vested PRSUs as of October 31, 2022 87,953 $ 58.63

The PRSUs granted during the three months ended October 31, 2021 had a weighted-average grant date fair value of $61.76. The total fair value of PRSUs vested during three months ended October 31, 2022 and 2021 was $889 and $4,098, respectively.

As of October 31, 2022, total unrecognized compensation cost related to PRSUs was $2,889 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.4 years.

NOTE JI — Net Income per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:


		Three months ended October 31,					Three months ended April 30,				Nine months ended April 30,
		2022		2021			2023		2022		2023		2022
Numerator (in thousands):	Numerator (in thousands):					Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	39,441	$	35,046	Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	48,052	$	40,054	$	125,479	$	108,915
Less:	Less:					Less:
Preferential dividends	Preferential dividends	(769)		(803)		Preferential dividends	—		—		(769)		(803)
Preferential dividends on dilutive stock options	Preferential dividends on dilutive stock options	(4)		(8)		Preferential dividends on dilutive stock options	—		—		(4)		(8)
Numerator for basic and diluted income per Class B Voting Common Share	Numerator for basic and diluted income per Class B Voting Common Share	$	38,668	$	34,235	Numerator for basic and diluted income per Class B Voting Common Share	$	48,052	$	40,054	$	124,706	$	108,104
Denominator (in thousands):	Denominator (in thousands):					Denominator (in thousands):
Denominator for basic income per share for both Class A and Class B	Denominator for basic income per share for both Class A and Class B	49,868		51,973		Denominator for basic income per share for both Class A and Class B	49,653		51,326		49,755		51,700
Plus: Effect of dilutive equity awards	Plus: Effect of dilutive equity awards	222		463		Plus: Effect of dilutive equity awards	348		242		278		355
Denominator for diluted income per share for both Class A and Class B	Denominator for diluted income per share for both Class A and Class B	50,090		52,436		Denominator for diluted income per share for both Class A and Class B	50,001		51,568		50,033		52,055
Net income per Class A Nonvoting Common Share:	Net income per Class A Nonvoting Common Share:					Net income per Class A Nonvoting Common Share:
Basic	Basic	$	0.79	$	0.67	Basic	$	0.97	$	0.78	$	2.52	$	2.11
Diluted	Diluted	$	0.79	$	0.67	Diluted	$	0.96	$	0.78	$	2.51	$	2.09
Net income per Class B Voting Common Share:	Net income per Class B Voting Common Share:					Net income per Class B Voting Common Share:
Basic	Basic	$	0.78	$	0.66	Basic	$	0.97	$	0.78	$	2.51	$	2.09
Diluted	Diluted	$	0.77	$	0.65	Diluted	$	0.96	$	0.78	$	2.49	$	2.08

Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value were greater than the average market price of the Company's Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares were ~~583,533~~447,210 and ~~479,602~~526,603 for the three months ended ~~October 31,~~April 30, 2023 and 2022, respectively, and ~~2021,~~555,247 and 492,527 for the nine months ended April 30, 2023 and 2022, respectively.

NOTE KJ — Fair Value Measurements

In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:

Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.

~~Table of Contents~~

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis ~~at October 31, 2022~~as of April 30, 2023 and July 31, 2022:

October 31, 2022

July 31, 2022

Fair Value Hierarchy

April 30, 2023

July 31, 2022

Fair Value Hierarchy

Assets:

Deferred compensation plan assets

16,072

18,037

Level 1

Deferred compensation plan assets

17,798

18,037

Level 1

Foreign exchange contracts

1,138

489

Level 2

Foreign exchange contracts

1,135

489

Level 2

Liabilities:

Foreign exchange contracts

—

Level 2

Foreign exchange contracts

Level 2

Table of Contents

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Deferred compensation plan assets: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in "Other assets" on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note L,K, “Derivatives and Hedging Activities,” for additional information.

The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

NOTE LK — Derivatives and Hedging Activities

The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate on a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.

Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:


		October 31, 2022		July 31, 2022			April 30, 2023		July 31, 2022
Designated as cash flow hedges	Designated as cash flow hedges	$	18,967	$	25,276	Designated as cash flow hedges	$	6,328	$	25,276
Non-designated hedges	Non-designated hedges	4,190		4,057		Non-designated hedges	4,670		4,057
Total foreign exchange contracts	Total foreign exchange contracts	$	23,157	$	29,333	Total foreign exchange contracts	$	10,998	$	29,333

Cash Flow Hedges

The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income ("OCI") and reclassified into income in the same period or periods during which the hedged transaction affects income. As of ~~October 31, 2022~~April 30, 2023 and July 31, 2022, unrealized gains of ~~$1,352~~$1,945 and $1,040 have been included in OCI, respectively.

Net Investment Hedges

The Company has designated certain third party foreign currency denominated debt borrowed under its credit agreement as net investment hedges. These debt obligations, denominated in Euros and British Pounds, were designated as net investment hedges to hedge portions of the Company's net investment in its European operations. The Company’s foreign currency denominated debt obligations are valued under a market approach using publicized spot prices, and the net gains or losses attributable to the changes in spot prices are recorded as cumulative translation within AOCI and are included in the foreign currency translation adjustments section of the condensed consolidated statements of comprehensive income. As of April 30, 2023 and July 31, 2022, the cumulative balance recognized in accumulated other comprehensive income were losses of $1,502 and $0, respectively, on any outstanding foreign currency denominated debt obligations.

Table of Contents

The following table summarizes the amount of pre-tax gains and losses related to ~~foreign exchange contracts~~derivatives designated as ~~cash flow~~ hedging instruments:


		Three months ended October 31,					Three months ended April 30,				Nine months ended April 30,
		2022		2021			2023		2022		2023		2022
Gains (losses) recognized in OCI		$	893	$	(26)
Gains (losses) recognized in OCI:						Gains (losses) recognized in OCI:
Forward exchange contracts (cash flow hedges)						Forward exchange contracts (cash flow hedges)	$	496	$	475	$	2,165	$	674
Foreign currency denominated debt (net investment hedges)						Foreign currency denominated debt (net investment hedges)	(661)		—		(1,502)		—
Gains reclassified from OCI into cost of goods sold	Gains reclassified from OCI into cost of goods sold	581		568		Gains reclassified from OCI into cost of goods sold
Forward exchange contracts (cash flow hedges)						Forward exchange contracts (cash flow hedges)	463		44		1,261		647

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:


		October 31, 2022				July 31, 2022					April 30, 2023						July 31, 2022
		Prepaid expenses and other current assets		Other current liabilities		Prepaid expenses and other current assets		Other current liabilities			Prepaid expenses and other current assets		Other current liabilities		Long-term obligations		Prepaid expenses and other current assets		Other current liabilities
Derivatives designated as hedging instruments:	Derivatives designated as hedging instruments:									Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	Foreign exchange contracts (cash flow hedges)	$	1,135	$	—	$	489	$	30	Foreign exchange contracts (cash flow hedges)	$	1,131	$	66	$	—	$	489	$	30
Foreign currency denominated debt (net investment hedges)										Foreign currency denominated debt (net investment hedges)	—		—		(37,849)		—		—
Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:									Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	Foreign exchange contracts (non-designated hedges)	3		—		—		2		Foreign exchange contracts (non-designated hedges)	4		—		—		—		2
Total derivative instruments	Total derivative instruments	$	1,138	$	—	$	489	$	32	Total derivative instruments	$	1,135	$	66	$	(37,849)	$	489	$	32

NOTE ~~M –~~L — Income Taxes

The income tax rate ~~was 21.6%~~ for the three months ended ~~October 31,~~April 30, 2023 and 2022, was 23.8% and ~~2021.~~21.8%, respectively. The income tax rate for the nine months ended April 30, 2023 and 2022, was 22.5% and 21.1%, respectively. The increase in the tax rate in both the three and nine-month periods was due to the sale of the PremiSys business as well as lapses in the statutes of limitations that did not reoccur in 2023. The Company expects its ongoing annual income tax rate to be approximately ~~20%~~21% based on its current global business mix and based on tax laws and statutory tax rates currently in effect.

NOTE NM — Subsequent Events

On November 14, 2022, the Company and certain of its subsidiaries entered into a Second Amendment to Credit Agreement (“Amendment No. 2”) with a group of six banks, which amends the original credit agreement dated as of August 1, 2019. Amendment No. 2 amends the credit agreement to, among other items, (a) increase the lending commitments by $100,000 for total lending commitments of $300,000 (b) extend the final maturity date to November 14, 2027, (c) increase the interest rate on certain borrowings by 0.125%, and (d) increase the available amount under the credit agreement, at the Company's option and subject to certain conditions, from $300,000 up to (i) an amount equal to the incremental borrowing necessary to bring the Company's consolidated net debt-to-EBITDA ratio to 2.5 to 1.0 plus(ii) $200,000. Borrowings under Amendment No. 2 remain unsecured and are guaranteed by certain of the Company's domestic subsidiaries. The credit agreement (as amended by Amendment No. 2) continues to contain various financial covenants, including a consolidated net debt-to-EBITDA ratio of 3.5 to 1.0 and a consolidated interest coverage ratio of 3.0 to 1.0.

~~On November~~May 16, ~~2022,~~2023, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.23 per share payable on ~~January~~July 31, 2023, to shareholders of record at the close of business on ~~January~~July 10, 2023.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. Effective February 1, 2023, the Company is organized and managed on a geographic basis with two reportable segments: Americas & Asia and Europe & Australia. As such, all segment-related data has been recast to reflect our new reportable segments in the Management's Discussion and Analysis of Financial Condition and Results of Operations section. Prior to February 1, 2023, the Company operated two former segments: Identification Solutions (“IDS”) and Workplace Safety (“WPS”). The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative identification and healthcare products. The WPS segment manufactures a broad range of stock and custom identification products and ~~sells~~is a ~~broad range~~distributor of a wide variety of resale products.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. Brady's long-term sales growth and profitability will depend not only on the overall economic environment and our ability to successfully navigate changes in the macro environment, but also on our ability to develop and market innovative new products, deliver a high level of customer service, advance our digital capabilities, and continuously improve the efficiency of our global operations. ~~In our IDS business, our~~Our strategy for growth includes an increased focus on ~~certain industries and products, a focus on improving the customer buying experience, and~~ the development of technologically advanced, innovative and proprietary ~~products. In our WPS business, our strategy for growth includes~~products and a focus on ~~workplace safety critical industries,~~providing customers with relevant, comprehensive and complimentary solutions. We are enhancing our omnichannel experience for customers, streamlining our product offerings ~~compliance expertise, customization expertise, improving the overall customer experience,~~ and improving our ~~digital capabilities.~~price competitiveness while delivering relevant products to our customers.

The following are key initiatives supporting our strategy in fiscal 2023:

•Investing in organic growth by enhancing our research and development process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.

•Providing our customers with the highest level of customer service.

•Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.

•Maintaining profitability through pricing mechanisms to mitigate the impacts of ongoing supply chain disruptions and inflationary pressures while ensuring prices are market competitive.

•Investing in acquisitions that enhance our strategic position and accelerate long-term sales ~~growth.~~growth and profitability.

•Driving operational excellence and executing sustainable efficiency gains within our selling, general and administrative structures and within our global operations including insourcing of critical products and manufacturing activities while reducing our environmental footprint and managing working capital.

•Building on our culture of diversity, equity and inclusion to increase employee engagement and enhance recruitment and retention practices in order to drive differentiated performance and execute our strategy.

~~Impact of the COVID-19 Pandemic~~•Executing our reorganization to a regional operating structure to support continued growth in key geographies, facilitate new product development in our recent acquisitions, and ~~other Global Geopolitical Events on Our Business~~simplify and further integrate our businesses.

Macroeconomic Conditions and Trends

The Company has experienced, and expects to continue to experience, ~~increased freight~~inflationary pressures and ~~input material cost inflation as a result of increased global demand, disruptions caused by COVID-19~~supply chain and ~~government-mandated actions in response to COVID-19, the conflict in the Ukraine, as well as labor shortages.~~other business disruptions. The Company has taken and will continue to take actions to mitigate inflation issues ~~but thus far has not fully offset the impact of these trends~~ through pricing ~~actions. As a result, these trends have negatively impacted~~actions and the ~~Company's gross profit margin.~~execution of sustainable efficiency gains.

We believe we have the financial strength to continue to invest in organic sales growth opportunities including sales, marketing, and research and development ("R&D") and inorganic sales opportunities including acquisitions, while continuing to drive sustainable efficiency gains and automation in our operations and selling, general and administrative ("SG&A") functions. At ~~October 31, 2022,~~April 30, 2023, we had cash of ~~$114.5~~$135.0 million, as well as a credit ~~facility~~agreement with ~~$99.4~~$247.6 million available for future borrowing, which can be increased up to ~~$299.4~~$1,047.6 million at the Company's option and subject to certain conditions, for total available liquidity of ~~$413.9~~$1,182.6 million.

We believe that our financial resources and liquidity levels, including the remaining undrawn amount of ~~the~~our credit ~~facility~~agreement and our ability to increase ~~that~~our credit line as necessary, are sufficient to manage the ~~continuing~~ impact of economic or geopolitical events which may result in reduced sales, ~~reduced~~ net income, ~~and reduced~~or cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2022, for further discussion of the ~~possible~~potential impact of global economic or geopolitical events or the COVID-19 pandemic ~~and other global geopolitical events~~ on our business.

Table of Contents

Results of Operations

A comparison of results of operating income for the three and nine months ended ~~October 31,~~April 30, 2023 and 2022, ~~and 2021~~ is as follows:


		Three months ended October 31,									Three months ended April 30,								Nine months ended April 30,
(Dollars in thousands)	(Dollars in thousands)	2022		% Sales		2021		% Sales		(Dollars in thousands)	2023		% Sales		2022		% Sales		2023		% Sales		2022		% Sales
Net sales	Net sales	$	322,569			$	321,475			Net sales	$	337,116			$	338,551			$	985,934			$	978,081
Gross margin	Gross margin	155,264		48.1	%	154,988		48.2	%	Gross margin	169,691		50.3	%	164,026		48.4	%	481,395		48.8	%	468,376		47.9	%
Operating expenses:	Operating expenses:									Operating expenses:
Research and development	Research and development	13,933		4.3	%	13,907		4.3	%	Research and development	15,715		4.7	%	14,923		4.4	%	45,025		4.6	%	42,795		4.4	%
Selling, general and administrative	Selling, general and administrative	89,945		27.9	%	96,746		30.1	%	Selling, general and administrative	90,975		27.0	%	96,214		28.4	%	273,202		27.7	%	285,485		29.2	%
Total operating expenses	Total operating expenses	103,878		32.2	%	110,653		34.4	%	Total operating expenses	106,690		31.6	%	111,137		32.8	%	318,227		32.3	%	328,280		33.6	%
Operating income	Operating income	$	51,386	15.9	%	$	44,335	13.8	%	Operating income	$	63,001	18.7	%	$	52,889	15.6	%	$	163,168	16.5	%	$	140,096	14.3	%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation, sales recorded from divested companies up to the first anniversary of their divestiture and sales recorded from acquired companies prior to the first anniversary date of their acquisition. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended ~~October 31, 2022, increased 0.3%~~April 30, 2023 declined 0.4% to ~~$322.6~~$337.1 million, compared to ~~$321.5~~$338.6 million in the same period in the prior year. Organic sales growth of 1.9% was offset by a decrease from foreign currency translation of 2.1% and a decrease of 0.2% due to the divestiture of a business. Organic sales grew 1.2% in the Americas & Asia segment and 3.4% in the Europe & Australia segment during the three months ended April 30, 2023 compared to the same period in the prior year.

Net sales for the nine months ended April 30, 2023 increased 0.8% to $985.9 million, compared to $978.1 million in the same period in the prior year. The increase consisted of organic sales growth of ~~6.9%~~5.0%, which was partially offset by a decrease from foreign currency translation of ~~6.6%.~~4.1% and a decrease of 0.1% due to the divestiture of a business. Organic sales ~~grew 8.6%~~increased 4.0% in the ~~IDS~~Americas & Asia segment and ~~grew 1.2%~~7.0% in the ~~WPS~~Europe & Australia segment during the ~~three~~nine months ended ~~October 31, 2022,~~April 30, 2023 compared to the same period in the prior year.

Gross margin increased ~~0.2%~~3.5% to ~~$155.3~~$169.7 million in the three months ended ~~October 31, 2022,~~April 30, 2023 compared to ~~$155.0~~$164.0 million in the same period in the prior year. As a percentage of net sales, gross margin ~~decreased~~increased to ~~48.1%~~50.3% from 48.4% in the three-month period. Gross margin increased 2.8% to $481.4 million for the nine months ended April 30, 2023 compared to ~~48.2%~~$468.4 million in the same period in the prior year. As a percentage of net sales, gross margin increased to 48.8% from 47.9% in the nine-month period. The ~~decrease~~increase in gross margin as a percentage of net sales was primarily due to ~~an increase~~operating efficiencies, reductions in ~~the cost of materials~~freight expenses and ~~labor, which was partially mitigated by price increases as well as our ongoing efforts~~pricing actions in response to ~~streamline manufacturing processes and drive sustainable operational efficiencies.~~higher costs.

R&D expenses ~~were consistent at $13.9~~increased 5.3% to $15.7 million ~~and 4.3% of sales~~ in the three months ended ~~October 31, 2022 and 2021.~~April 30, 2023 compared to $14.9 million in the same period in the prior year. As a percentage of net sales, R&D expenses increased to 4.7% from 4.4% in the three-month period. R&D expenses increased 5.2% to $45.0 million in the nine months ended April 30, 2023 compared to $42.8 million in the same period in the prior year. As a percentage of net sales, R&D expenses increased to 4.6% from 4.4% in the nine-month period. The Company remains committed to investing in new product development to increase sales within our ~~IDS and WPS~~ businesses. Investments in new ~~printing systems,~~printers, materials and the build out of ~~a comprehensive~~ industrial track and trace ~~solution~~solutions remain the primary focus of R&D expenditures for the remainder of fiscal 2023.

SG&A expenses include selling and administrative costs directly attributed to the ~~IDS~~Americas & Asia and ~~WPS~~Europe & Australia segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses decreased ~~7.0%~~5.4% to ~~$89.9~~$91.0 million in the three months ended ~~October 31, 2022,~~April 30, 2023 compared to ~~$96.7~~$96.2 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to ~~27.9%~~27.0% from 28.4% in the three-month period. SG&A expenses decreased 4.3% to $273.2 million for the ~~three~~nine months ended ~~October 31, 2022,~~April 30, 2023 compared to 30.1% in the same period in the prior year. The decrease in SG&A expenses was primarily due to foreign currency translation and to a lesser extent, reductions in catalog advertising expenses within the WPS segment.

~~Operating income increased 15.9% to $51.4 million in the three months ended October 31, 2022, compared to $44.3~~$285.5 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to 27.7% from 29.2% in the nine-month period. SG&A expenses include a gain of $3.8 million from the sale of the PremiSys business during the three months ended April 30, 2023. The ~~increase~~decrease in ~~operating income~~SG&A expenses during the three and nine months ended April 30, 2023 was due to ~~an increase in segment profit in~~foreign currency translation, the ~~WPS~~gain on the sale of the divested business ~~due to actions taken last fiscal year to reduce the cost structure along with~~and ongoing ~~reductions in catalog advertising expenses, as well as an increase in IDS segment profit resulting from organic sales growth.~~efficiency activities.

Table of Contents

Operating income increased 19.1% to $63.0 million and increased 16.5% to $163.2 million for the three and nine months ended April 30, 2023, respectively, compared to $52.9 million and $140.1 million in the same periods in the prior year. The increase in operating income in both the three and nine-month periods was primarily due to the increase in segment profit in the Americas & Asia segment as a result of organic sales growth and the realization of pricing actions taken during fiscal 2022 and the beginning of fiscal 2023, and to a lesser extent due to the gain on the sale of the PremiSys business.

OPERATING INCOME TO NET INCOME


		Three months ended October 31,									Three months ended April 30,								Nine months ended April 30,
(Dollars in thousands)	(Dollars in thousands)	2022		% Sales		2021		% Sales		(Dollars in thousands)	2023		% Sales		2022		% Sales		2023		% Sales		2022		% Sales
Operating income	Operating income	$	51,386	15.9	%	$	44,335	13.8	%	Operating income	$	63,001	18.7	%	$	52,889	15.6	%	$	163,168	16.5	%	$	140,096	14.3	%
Other (expense) income:
Investment and other (expense) income		(157)		0.0	%	543		0.2	%
Other income (expense):										Other income (expense):
Investment and other income (expense)										Investment and other income (expense)	785		0.2	%	(1,308)		(0.4)	%	1,596		0.2	%	(1,343)		(0.1)	%
Interest expense	Interest expense	(894)		(0.3)	%	(182)		(0.1)	%	Interest expense	(753)		(0.2)	%	(329)		(0.1)	%	(2,886)		(0.3)	%	(763)		(0.1)	%
Income before income taxes	Income before income taxes	50,335		15.6	%	44,696		13.9	%	Income before income taxes	63,033		18.7	%	51,252		15.1	%	161,878		16.4	%	137,990		14.1	%
Income tax expense	Income tax expense	10,894		3.4	%	9,650		3.0	%	Income tax expense	14,981		4.4	%	11,198		3.3	%	36,399		3.7	%	29,075		3.0	%
Net income	Net income	$	39,441	12.2	%	$	35,046	10.9	%	Net income	$	48,052	14.3	%	$	40,054	11.8	%	$	125,479	12.7	%	$	108,915	11.1	%

Investment and other ~~expense~~income was ~~$0.2~~$0.8 million inand $1.6 million for the three and nine months ended ~~October 31, 2022,~~April 30, 2023, respectively, compared to investment and other ~~income~~expense of ~~$0.5~~$1.3 million in both the ~~same period~~three and nine-month periods in the prior year. The ~~change~~increase in income during the three and nine-month periods was primarily due to ~~a decrease~~an increase in the market value of securities held in deferred compensation plans ~~during the three months ended October 31, 2022.~~and, to a lesser extent, an increase in interest income.

Interest expense increased to ~~$0.9~~$0.8 million inand $2.9 million for the three and nine months ended ~~October 31, 2022,~~April 30, 2023, respectively, compared to ~~$0.2~~$0.3 million and $0.8 million in the same ~~period~~periods in the prior year. The increase in interest expense was primarily due to an increase in benchmark interest rates ~~in the Company's revolving loan agreement and partially due to an increase in outstanding borrowings on the Company's revolving loan agreement~~ compared to the same ~~period~~periods in the prior year.

The ~~Company’s~~Company's income tax rate was ~~21.6%~~23.8% and 21.8% for the three months ended ~~October 31,~~April 30, 2023 and 2022, respectively, and ~~2021.~~the income tax rate was 22.5% and 21.1% for the nine months ended April 30, 2023 and 2022, respectively. Refer to Note ML, "Income Taxes" for additional information on the Company's income tax ~~rate.~~rates.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income (expense) ~~income,~~, income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.

Table of Contents

The following is a summary of segment information for the three and nine months ended ~~October 31, 2022~~April 30, 2023 and ~~2021:~~2022:


		Three months ended October 31,							Three months ended April 30,						Nine months ended April 30,
		2022			2021				2023			2022			2023			2022
SALES GROWTH INFORMATION	SALES GROWTH INFORMATION							SALES GROWTH INFORMATION
IDS
Americas & Asia								Americas & Asia
Organic	Organic	8.6		%	13.2		%	Organic	1.2		%	9.2		%	4.0		%	10.7		%
Currency	Currency	(5.5)		%	0.6		%	Currency	(0.8)		%	(0.1)		%	(1.1)		%	0.3		%
Acquisitions		—		%	11.6		%
Divestiture								Divestiture	(0.3)		%	—		%	(0.1)		%	—		%
Acquisition								Acquisition	—		%	8.6		%	—		%	8.3		%
Total	Total	3.1		%	25.4		%	Total	0.1		%	17.7		%	2.8		%	19.3		%
WPS
Europe & Australia								Europe & Australia
Organic	Organic	1.2		%	(8.6)		%	Organic	3.4		%	8.4		%	7.0		%	7.6		%
Currency	Currency	(10.3)		%	0.8		%	Currency	(4.8)		%	(8.1)		%	(10.1)		%	(4.6)		%
Acquisition								Acquisition	—		%	8.7		%	—		%	8.8		%
Total	Total	(9.1)		%	(7.8)		%	Total	(1.4)		%	9.0		%	(3.1)		%	11.8		%
Total Company	Total Company							Total Company
Organic	Organic	6.9		%	7.0		%	Organic	1.9		%	9.0		%	5.0		%	9.6		%
Currency	Currency	(6.6)		%	0.7		%	Currency	(2.1)		%	(3.0)		%	(4.1)		%	(1.5)		%
Acquisitions		—		%	8.3		%
Divestiture								Divestiture	(0.2)		%	—		%	(0.1)		%	—		%
Acquisition								Acquisition	—		%	8.6		%	—		%	8.5		%
Total	Total	0.3		%	16.0		%	Total	(0.4)		%	14.6		%	0.8		%	16.6		%
SEGMENT PROFIT	SEGMENT PROFIT							SEGMENT PROFIT
IDS		$	51,525		$	48,816
WPS		6,378			2,293
Americas & Asia								Americas & Asia	$	49,192		$	45,021		$	130,511		$	114,659
Europe & Australia								Europe & Australia	17,099			16,050			47,316			46,165
Total	Total	$	57,903		$	51,109		Total	$	66,291		$	61,071		$	177,827		$	160,824
SEGMENT PROFIT AS A PERCENT OF NET SALES	SEGMENT PROFIT AS A PERCENT OF NET SALES							SEGMENT PROFIT AS A PERCENT OF NET SALES
IDS		20.1		%	19.6		%
WPS		9.6		%	3.1		%
Americas & Asia								Americas & Asia	22.1		%	20.2		%	19.7		%	17.8		%
Europe & Australia								Europe & Australia	15.0		%	13.8		%	14.6		%	13.8		%
Total	Total	18.0		%	15.9		%	Total	19.7		%	18.0		%	18.0		%	16.4		%

~~Table of Contents~~

Americas & Asia

~~IDS~~

~~IDS~~Americas & Asia net sales ~~increased 3.1% to $256.4~~were essentially flat at $222.8 million infor the three months ended ~~October 31, 2022,~~April 30, 2023 compared to ~~$248.6~~$222.6 million in the same period in the prior year, which consisted of organic sales growth of ~~8.6%~~1.2% and ~~a decrease~~decreases from foreign currency translation of ~~5.5%~~0.8% and the sale of the PremiSys business of 0.3%. ~~Organic~~Americas & Asia net sales ~~grew in all major product lines with~~increased 2.8% to $661.4 million for the ~~most significant growth~~nine months ended April 30, 2023 compared to $643.3 million in the ~~safety and facility identification product line, followed by growth~~same period in the ~~product identification, wire identification~~prior year, which consisted of organic sales growth of 4.0% and ~~healthcare identification product lines.~~decreases from foreign currency translation of 1.1% and the sale of the PremiSys business of 0.1%.

Organic sales in the Americas increased in the ~~mid-single~~low-single digits ~~organic sales in Europe increased~~ in the ~~mid-teens,~~three months ended April 30, 2023 and ~~organic sales in Asia~~ increased in the mid-single digits in the nine months ended April 30, 2023 compared to the same periods in the prior year. The increase in organic sales during the three-month period was primarily due to organic sales growth in IDS with the strongest growth in the safety and facility identification and healthcare identification product lines, which was partially offset by organic sales declines in wire identification and product identification. During the nine-month period, organic sales grew in the safety and facility identification, healthcare identification and wire identification product lines, which was partially offset by an organic sales decline in the product identification product line. Organic growth in IDS was partially offset by a mid-single digit organic decline in WPS during both the three and nine months ended April 30, 2023.

Organic sales in Asia declined in the low-single digits in the both the three and nine-month periods ended April 30, 2023 compared to the same periods in the prior year. The organic sales decline during the three-month period was primarily driven by decreased sales in Malaysia and Singapore, which were partially offset by sales growth in China and India. The organic sales decline during the nine-month period was primarily driven by decreased sales in China due to the spread of COVID-19 during the second quarter of fiscal 2023, which was partially offset by strong sales growth in India and Japan during the nine-month period.

Americas & Asia segment profit increased 9.3% to $49.2 million for the three months ended ~~October 31, 2022~~April 30, 2023 compared to $45.0 million in the same period in the prior year.

Segment profit increased ~~5.5%~~13.8% to ~~$51.5~~$130.5 million infor the ~~three~~nine months ended ~~October 31, 2022,~~

Table of Contents

April 30, 2023 compared to ~~$48.8~~$114.7 million in the same period in the prior year. As a percentage of net sales, segment profit ~~was 20.1%~~increased to 22.1% from 20.2% for the three-month period, and segment profit increased to 19.7% from 17.8% for the nine-month period ended April 30, 2023 compared to ~~19.6%~~the same periods in the prior year. The increase in segment profit as a percentage of net sales was primarily due to ongoing efforts to streamline processes to drive operational efficiencies as well as price increases, which were partially offset by an increase in costs due to inflationary pressures.

Europe & Australia

Europe & Australia net sales declined 1.4% to $114.3 million for the three months ended April 30, 2023 compared to $116.0 million in the same period in the prior year, which consisted of organic sales growth of 3.4% and a decrease from foreign currency translation of 4.8%. Europe & Australia net sales declined 3.1% to $324.6 million for the nine months ended April 30, 2023 compared to $334.8 million in the same period in the prior year, which consisted of organic sales growth of 7.0% and a decrease from foreign currency translation of 10.1%.

Organic sales in Europe increased in the low-single digits in the three months ended April 30, 2023 and increased in the mid-single digits in the nine months ended April 30, 2023 compared to the same periods in the prior year. The increase in organic sales during the three-month period was primarily driven by mid-single digit growth within WPS, which included digital sales growth of approximately 15%. Organic sales in IDS increased in the low-single digits during the three-month period, which consisted of growth in the safety and facility identification product line, which was partially offset by a decline in the product identification and wire identification product lines. Organic sales growth during the nine-month period was driven by mid-single digit growth in both IDS and WPS. Organic sales growth in IDS was strongest in the safety and facility identification and product identification product lines, followed by wire identification. Organic sales in WPS included digital sales growth of approximately 13%.

Organic sales in Australia increased in the low-teens in both the three and nine months ended April 30, 2023 compared to the same periods in the prior year. Organic sales were driven by consistent growth in both digital and sales from all other channels, including catalogs, in both the three and nine-month periods, which was primarily the result of price increases implemented throughout the nine months ended April 30, 2023. Organic sales growth was led by core safety and facility identification products.

Europe & Australia segment profit increased 6.5% to $17.1 million from $16.1 million, and as a percentage of net sales, segment profit increased to 15.0% from 13.8% for the three months ended April 30, 2023 compared to the same period in the prior year. Segment profit increased 2.5% to $47.3 million from $46.2 million and as a percentage of net sales, segment profit increased to 14.6% from 13.8% for the nine months ended April 30, 2023 compared to the same period in the prior year. The increase in segment profit ~~was primarily due to increased sales volumes in all regions and all major product lines globally.~~

~~WPS~~

WPS net sales declined 9.1% to $66.2 million in the three months ended October 31, 2022, compared to $72.9 million in the same period in the prior year, which consisted of an organic sales increase of 1.2% and a decrease from foreign currency translation of 10.3%. Organic digital sales increased by nearly 13% and organic catalog sales declined in the low-single digits in the three-month period.

Organic sales in Europe increased in the mid-single digits consisting of digital sales growth of approximately 10% and low-single digit catalog channel sales growth. Organic sales in North America declined by approximately 11% primarily due to actions taken to improve price competitiveness and simplify our product offering, which contributed to the significant improvement in segment profit in the three-month period. Organic sales in Australia increased by approximately 11% in the three months ended October 31, 2022 compared to the same period in the prior year consisting of high-single digit digital sales growth and catalog channel sales growth of approximately 12%.

Segment profit increased 178.2% to $6.4 million in the three months ended October 31, 2022, compared to $2.3 million in the same period of the prior year. As a percentage of net sales, segment profit improved to 9.6% compared to 3.1% in the same period of the prior year. The increase in segment profitfor both periods was primarily due to actions taken during fiscal 2022 to reduce the cost structure as well as ~~ongoing reductions in catalog advertising expenses.~~pricing actions implemented throughout the nine months ended April 30, 2023.

Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At ~~October 31, 2022, approximately 95%~~April 30, 2023, 99% of the Company's cash and cash equivalents were held outside the United States. The Company's organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 ~~months.~~months and beyond. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

Table of Contents

Cash Flows

Cash and cash equivalents were ~~$114.5~~$135.0 million at ~~October 31, 2022,~~April 30, 2023, an increase of ~~$0.4~~$21.0 million from July 31, 2022. The significant changes were as follows:

Three months ended October 31,
(Dollars in thousands) 2022 2021
Net cash flow provided by (used in):
Operating activities $ 27,999 $ 27,491
Investing activities (3,861) (11,326)
Financing activities (20,535) (4,592)
Effect of exchange rate changes on cash (3,201) (1,355)
Net increase in cash and cash equivalents $ 402 $ 10,218

~~Table of Contents~~


	Nine months ended April 30,
(Dollars in thousands)	2023		2022
Net cash flow provided by (used in):
Operating activities	$	129,861	$	65,236
Investing activities	(4,901)		(22,071)
Financing activities	(105,935)		(81,762)
Effect of exchange rate changes on cash	1,953		(5,670)
Net increase (decrease) in cash and cash equivalents	$	20,978	$	(44,267)

Net cash provided by operating activities was ~~$28.0~~$129.9 million infor the ~~three~~nine months ended ~~October 31, 2022,~~April 30, 2023 compared to ~~$27.5~~$65.2 million in the same period of the prior year. The ~~use of~~increase in cash ~~from working capital~~provided by operating activities was ~~reduced~~ primarily due to ~~a decrease in the amount of~~improved profitability and reduced inventory purchases compared to elevated inventory purchases in the ~~current quarter, which was offset by~~prior year to reduce the ~~annual cash incentive plan payment made in the current quarter compared to the second quarter~~risk of ~~the prior year.~~supply chain disruption.

Net cash used in investing activities was $4.9 million in the nine months ended April 30, 2023, which consisted ~~of $3.9 million~~ of capital expenditures of $12.9 million partially offset by proceeds of $8.0 million received from the sale of the PremiSys business. Net cash used in investing activities was $22.1 million in the ~~three~~nine months ended ~~October 31,~~April 30, 2022, ~~compared to $11.3 million of capital expenditures in the same period of the prior year. Prior year capital expenditures were~~which was elevated due to the purchase of two facilities that were previously leased.

Net cash used in financing activities was ~~$20.5~~$105.9 million in the ~~three~~nine months ended ~~October 31, 2022~~April 30, 2023 compared to ~~$4.6~~$81.8 million in the same period of the prior year. ~~Net~~The increase in cash used by financing activities was primarily due to $44.2 million of net repayments on the credit agreement in the nine months ended April 30, 2023 compared to $39.0 million of net borrowings on the credit ~~facility declined by $25.0 million primarily~~agreement in the same period of the prior year, which was due to ~~reduced capital expenditures and~~the increase in net cash provided by operating activities in the current nine-month period. The increase in cash used in financing activities was partially offset by a decrease in share repurchases ~~in the three months ended October 31, 2022~~ compared to the ~~same period in the~~ prior ~~year.~~period.

Material Cash Requirements

Our material cash requirements for known contractual obligations include capital expenditures, borrowings on our credit ~~facilities~~agreement and lease obligations. We believe that net cash provided by operating activities will continue to be adequate to meet our liquidity and capital needs for these items over ~~the short-term in~~ the next 12 months and in the long-term beyond the next 12 months. We also have cash requirements for purchase orders and contracts for the purchase of inventory and other goods and services, which are based on current and anticipated customer needs and are fulfilled by our suppliers within short time horizons. We do not have significant agreements for the purchase of inventory or other goods or services specifying minimum order quantities. In addition, we may have liabilities for uncertain tax positions, but we do not believe that the cash requirements to meet any of these liabilities will be material.

Credit ~~Facilities~~Agreement

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency ~~revolving loan~~credit agreement with a group of five banks. ~~At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million.~~

On December 21, 2021, the Company and certain of its subsidiaries entered into an amendment to the ~~revolving loan agreement, which amends the revolving loan~~credit agreement dated August 1, 2019. The amendment ~~amends~~modified the ~~revolving loan~~credit agreement to, among other ~~items,~~things, (a) change the interest rate under the ~~revolving loan~~credit agreement for borrowings (i) denominated in British Pounds from the London Inter-bank Offered Rate ("LIBOR") to a daily simple SONIA-based rate, (ii) denominated in Euro from a LIBOR-based rate to a rate based on the Euro Interbank Offered Rate and (iii) denominated in Japanese Yen from a LIBOR-based rate to a rate based on the Tokyo Interbank Offered Rate, in each of the foregoing cases subject to certain adjustments specified in the ~~revolving loan~~credit agreement; and (b) provide mechanics relating to a transition away from U.S. dollar LIBOR (with respect to borrowings denominated in U.S. dollars) and the designated benchmarks for the other eligible currencies as benchmark interest rates and the replacement of any such benchmark by a replacement benchmark rate. The amendment to the ~~revolving loan~~credit agreement did not have a material impact on the interest rate or related balances in the Company's consolidated financial statements.

On November 14, 2022, the Company and certain of its subsidiaries entered into a Second Amendment to Credit Agreement (“Amendment No. 2”) with a group of six banks, which amended the original credit agreement dated August 1,

Table of Contents

2019. Amendment No. 2 amended the credit agreement to, among other items, (a) increase the lending commitments by $100 million for total lending commitments of $300 million, (b) extend the final maturity date to November 14, 2027, (c) increase the interest rate on certain borrowings by 0.125%, and (d) increase the available amount under the credit agreement, at the Company's option and subject to certain conditions, from $300 million up to (i) an amount equal to the incremental borrowing necessary to bring the Company's consolidated net debt-to-EBITDA ratio as defined in the credit agreement to 2.5 to 1.0 plus (ii) $200 million. Borrowings under Amendment No. 2 are unsecured and are guaranteed by certain of the Company's domestic subsidiaries.

As of ~~October 31, 2022,~~April 30, 2023, the outstanding balance on the Company's ~~revolving loan~~credit agreement was ~~$99.0~~$50.8 million. The maximum amount outstanding on the credit ~~facility~~agreement during the ~~three~~nine months ended ~~October 31, 2022~~April 30, 2023 was ~~$101.0~~$103.0 million. ~~The~~As of April 30, 2023, the U.S. dollar-denominated borrowings of $13.0 million bear interest at ~~4.09% as~~6.0%; the Euro-denominated borrowings of ~~October 31, 2022.~~€23.0 million bear interest at 3.9%; and the British Pound-denominated borrowings of £10.0 million bear interest at 5.1% for a weighted average interest rate of 4.7%. The Company had letters of credit outstanding under the ~~loan~~credit agreement of $1.6 million as of ~~October 31, 2022~~April 30, 2023, and there was ~~$99.4~~$247.6 million available for future borrowing, which can be increased to ~~$299.4~~$1,047.6 million at the Company's option, subject to certain conditions. The ~~revolving loan~~credit agreement has a final maturity date of ~~August 1, 2024.~~November 14, 2027. As such, borrowings were classified as long-term on the ~~Condensed Consolidated Balance Sheets.~~

~~Refer to Item 1, Note N, "Subsequent Events" for information regarding the Company's subsequent events affecting financial condition.~~condensed consolidated balance sheets.

Covenant Compliance

The Company's ~~revolving loan~~credit agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the ~~debt agreements,~~credit agreement, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of ~~October 31, 2022,~~April 30, 2023, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the ~~agreements,~~agreement, equal to ~~0.38~~0.19 to 1.0 and the interest expense coverage ratio equal to ~~125.1~~77.1 to 1.0.

~~Table of Contents~~

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

•Increased cost of raw materials, labor and freight as well as raw material shortages and supply chain disruptions

•~~Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics~~

•Decreased demand for the Company's products

•Ability to compete effectively or to successfully execute ~~its~~the Company's strategy

•Ability to develop technologically advanced products that meet customer demands

•Ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses

•Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics

•Difficulties in protecting websites, networks, and systems against security breaches and difficulties in preventing phishing attacks, social engineering or malicious ~~break-ins.~~break-ins

•Risks associated with the loss of key employees

•Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities

•Litigation, including product liability claims

•Foreign currency fluctuations

•Potential write-offs of goodwill and other intangible assets

•Changes in tax legislation and tax rates

•Differing interests of voting and non-voting shareholders

•Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2022.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Refer to the Company’s ~~annual report~~Annual Report on Form 10-K for the year ended July 31, 2022. There has been no material change in this information since ~~July 31, 2022.~~the 2022 Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer (the "Chief Executive Officer") and its Chief Financial Officer, Chief Accounting Officer and Treasurer (the "Chief Financial Officer"), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s ~~President &~~ Chief Executive Officer and Chief Financial Officer ~~and Treasurer~~ concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

~~Table of Contents~~

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

2324

Table of Contents

PART II. OTHER INFORMATION

ITEM 1A. RISK FACTORS

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Company’s ~~annual report~~Annual Report on Form 10-K for the year ended July 31, 2022. There have been no material changes from the risk factors set forth in the 2022 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company has a share repurchase program for the Company's Class A Nonvoting Common Stock. The ~~plan~~repurchase program may be implemented by purchasing shares in the open market or in privately negotiated transactions, with repurchased shares available for use in connection with the Company's stock-based plans and for other corporate purposes. On May 24, 2022, the Company's Board of Directors authorized an increase in the Company's share repurchase program, authorizing the repurchase of up to $100.0 million of the Company's Class A Nonvoting Common Stock. As of ~~October 31, 2022,~~April 30, 2023, there were ~~$72.9~~$55.2 million worth of shares authorized to purchase remaining pursuant to the existing share repurchase program.

The following table provides information with respect to the purchases by the Company of Class A Nonvoting Common Stock during the three months ended ~~October 31, 2022:~~April 30, 2023:

Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
(Dollars in Thousands)
August 1, 2022 - August 31, 2022 — $ — — $ 85,010
September 1, 2022 - September 30, 2022 255,814 43.30 255,814 73,932
October 1, 2022 - October 31, 2022 23,699 41.88 23,699 72,939
Total 279,513 $ 43.18 279,513 $ 72,939


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan (Dollars in Thousands)
February 1, 2023 - February 28, 2023	—	$	—	—	$	67,148
March 1, 2023 - March 31, 2023	70,566	51.83		70,566	63,491
April 1, 2023 - April 30, 2023	158,754	52.00		158,754	55,235
Total	229,320	$	51.95	229,320	$	55,235

2425

Table of Contents

ITEM 6. EXHIBITS


Exhibit No.						Exhibit Description

10.1						~~Settlement~~Complete and Permanent Release and Resignation Agreement between the Company and ~~Mr. Deman~~Aaron J. Pearce dated as of ~~October 10, 2022~~April 13, 2023 (incorporated by reference to Registrant's Current ~~report~~Report on Form 8-K filed ~~October 11, 2022)~~April 19, 2023).*

10.2						~~Second Amendment to Credit Agreement, among~~Employment Offer Letter between the Company and ~~the lenders listed therein,~~Ann E. Thornton dated as of ~~November~~April 14, ~~2022~~2023 (incorporated by reference to Registrant's Current ~~report~~Report on Form 8-K filed ~~November 15, 2022)~~April 19, 2023).*

10.3						Change of Control Agreement between the Company and Ann E. Thornton dated as of April 14, 2023 (incorporated by reference to Registrant's Current Report on Form 8-K filed April 19, 2023).*

31.1						Rule 13a-14(a)/15d-14(a) Certification of Russell R. Shaller

31.2						Rule 13a-14(a)/15d-14(a) Certification of ~~Aaron J. Pearce~~Ann E. Thornton

32.1						Section 1350 Certification of Russell R. Shaller

32.2						Section 1350 Certification of ~~Aaron J. Pearce~~Ann E. Thornton

101.INS						XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)

101.SCH						XBRL Taxonomy Schema Document

101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Presentation Label Linkbase Document

104						Cover Page Inline XBRL data (contained in Exhibit 101)


*			Management contract or compensatory plan or arrangement

2526

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BRADY CORPORATION

Date: ~~November 17, 2022~~May 18, 2023

/s/ RUSSELL R. SHALLER

Russell R. Shaller

President and Chief Executive Officer

(Principal Executive Officer)

Date: ~~November 17, 2022~~May 18, 2023

/s/ ~~AARON J. PEARCE~~ANN E. THORNTON

~~Aaron J. Pearce~~Ann E. Thornton

Chief Financial Officer, Chief Accounting Officer and Treasurer

(Principal Financial Officer and Principal Accounting Officer)

2627



			Page
PART I. Financial Information			3
Item 1. Financial Statements (Unaudited)			3
Condensed Consolidated Balance Sheets			3
Condensed Consolidated Statements of Income			4
Condensed Consolidated Statements of Comprehensive Income			5
Condensed Consolidated Statements of Stockholders' Equity			6
Condensed Consolidated Statements of Cash Flows			78
Notes to Condensed Consolidated Financial Statements			89
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			17
Item 3. Quantitative and Qualitative Disclosures About Market Risk			2224
Item 4. Controls and Procedures			2224
PART II. Other Information			2425
Item 1A. Risk Factors			2425
Item 2. Unregistered ~~Sales~~Sale of Equity Securities and Use of Proceeds			2425
Item 6. Exhibits			2526
Signatures			2627


	Three months ended October 31,
Black-Scholes Option Valuation Assumptions	2022		2021
Expected term (in years)	5.7		6.1
Expected volatility	29.6	%	30.0	%
Expected dividend yield	2.0	%	2.3	%
Risk-free interest rate	3.7	%	1.0	%


Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2022	1,591,525	$	41.57
Granted	147,629	43.50
Exercised	(22,494)	30.48
Forfeited	(10,247)	45.41
Outstanding at October 31, 2022	1,706,413	$	41.86	6.4	$	9,729
Exercisable at October 31, 2022	1,270,763	$	40.67	5.4	$	8,851


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested RSUs as of July 31, 2022	173,230	$	47.45
Granted	62,197	44.70
Vested	(61,316)	47.50
Forfeited	(2,585)	45.03
Non-vested RSUs as of October 31, 2022	171,526	$	46.47


	Three months ended October 31,
Monte Carlo Valuation Assumptions	2022		2021
Expected volatility	34.8	%	34.7	%
Risk-free interest rate	2.8	%	0.3	%


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested PRSUs as of July 31, 2022	79,134	$	66.79
Granted	44,110	55.77
Vested	(18,959)	75.00
Forfeited	(16,332)	71.99
Non-vested PRSUs as of October 31, 2022	87,953	$	58.63